Dr. Charles L. Secrest, MD

Dr. Secrest practices at Baylor Scott & White Medical Center - Grapevine in Grapevine, Texas, part of Baylor Scott & White Health.

Dr. Secrest's NPI, 1588695654, was assigned on July 6, 2006. Dr. Secrest graduated from University of Mississippi Medical Center - Jackson in 1986. Dr. Secrest holds Texas license H2964.

Dr. Secrest's primary practice is Baylor Scott & White Medical Center - Grapevine, at 1650 W College St, Grapevine, TX 76051 in Tarrant County. The practice phone is (817) 481-1588.

Dr. Secrest's primary practice is Baylor Scott & White Medical Center - Grapevine in Grapevine, Texas, part of Baylor Scott & White Health. Dr. Secrest is also affiliated with Baylor Scott & White All Saints Medical Center - Fort Worth. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Secrest to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Secrest practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Secrest's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Secrest is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Secrest's licenses on file in 2 states: Texas and Mississippi.

Dmand AI lists bladder disease, bladder removal, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, pelvic prolapse and testicular dysfunction among the conditions Dr. Secrest treats.

CMS data shows 4,525 Medicare services from Dr. Secrest across 19 procedure codes in 2024, for 238 Medicare patients. Medicare paid $98,921 for them.

CMS counts 238 Medicare patients who saw Dr. Secrest in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Secrest's median patient age at 67, with 48% women.

In 2024, Dr. Secrest wrote 310 Medicare Part D claims for 107 patients. 74% of them were for generic drugs. CMS names the drug for 230 of them, across 7 drugs with 11 or more claims each, at $45,015 in total drug cost. In 2023, CMS named 214 claims across 6 drugs.

Dr. Secrest accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Secrest, published from 2012 to 2020. 2013 was the busiest year, with 2. The most frequent topics are Postoperative Complications, Biocompatible Materials and Erectile Dysfunction. Dr. Secrest has published most often in J Urol. Dr. Secrest's most frequent co-authors are Robert M. Goldstein, MD, Bo S. Husberg, MD and Goran B. G. Klintmalm, MD.

CMS Open Payments shows 225 general payments to Dr. Secrest from 46 drug and device companies from 2016 to 2025. Education make up the largest share, 75% of the total. Intuitive Surgical, Inc. paid the most, $16,752.

Dmand AI lists 1 award for Dr. Secrest, most recently CMS Stage 1 EHR in 2013.

Dr. Secrest graduated from University of Mississippi Medical Center - Jackson in 1986.

Dr. Secrest is in network with 20 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.